What is ixLayer?
ixLayer offers a unified direct-to-patient platform designed to enhance the patient experience for biopharma companies. Their comprehensive services encompass virtual patient experiences, telehealth, lab testing, prescription fulfillment, and benefits verification, all aimed at simplifying and accelerating the connection to care. By improving patient activation and diagnostic testing compliance, ixLayer empowers biopharma clients with a seamless healthcare journey that boosts operational efficiency and elevates patient outcomes. The company's focus on bridging the gap between patients and healthcare providers positions it as a key innovator in digital health solutions.
How much funding has ixLayer raised?
ixLayer has raised a total of $75M across 1 funding round:
Series A
$75M
Series A (2021): $75M with participation from Hamid Moghadam, Dara Khosrowshahi, Zeshan Muhammedi, General Catalyst, PearVC, Bobby Yazdani, and Anne Wojcicki
Key Investors in ixLayer
General Catalyst
General Catalyst is a venture capital firm that invests in transformational business opportunities across various sectors and stages, focusing on backing ambitious entrepreneurs and management teams. They provide strategic capital and operational support to accelerate growth and build enduring enterprises.
PearVC
PearVC is an investment firm that provides capital to support the growth and development of companies. Their involvement suggests a strategic interest in ixLayer's market position and future potential.
Undisclosed Investor
An undisclosed investor participated in this funding round, indicating a strategic interest in ixLayer's direct-to-patient platform and its impact on the biopharma industry.
What's next for ixLayer?
The recent major strategic investment signifies a critical growth phase for ixLayer, likely enabling expansion of its platform capabilities and market reach within the biopharma sector. This capital infusion is expected to accelerate product development, enhance strategic partnerships, and solidify its position as a leader in direct-to-patient healthcare solutions. The company's trajectory suggests a strong emphasis on scaling operations and further integrating its technology to meet the growing demand for streamlined patient engagement and diagnostic services.
See full ixLayer company page
